Australians will no longer be able to access Truvada, used for HIV treatment as well as for pre-exposure prophylaxis (PrEP), through the Pharmaceutical Benefits Scheme (PBS). Truvada was delisted from the subsidy scheme from April 1, 2020. The Australian Federation of AIDS Organisations said that there were alternatives to Truvada for PrEP in Australia.